A spin-off from Philips Study.

Based on optical technology the device poses no risk for the patient and is usually fast, operator independent, easy and inexpensive to use. The technology isn’t related to Philips primary imaging modalities and affected individual monitoring solutions. Dr. Wouter Dr and Rensen. Michiel van Beek, co-founders of Akeso, invented and developed the RA optical irritation detection technology within Philips Analysis. Dr. Regular objective monitoring of irritation permits fine-tuning of the treatment of RA, leading to earlier remission, fewer inflammatory episodes and much less pain for patients, in the long term reducing functional loss and lowering healthcare costs and financial losses.The Flex range may be the newest addition to the Acticoat portfolio of dressings with NUCRYST’s proprietary SILCRYST nanocrystalline silver coatings. Acticoat Flex is an antimicrobial barrier dressing designed to comply with body contours and invite for flexible motion for injuries that want sustained antimicrobial activity. ‘We are very happy to support Smith Nephew in the European start of Acticoat Flex,’ stated David B. Holtz, Interim Chief and President Executive Officer, and Chief Financial Officer of NUCRYST. ‘The enhanced conformability of Flex will right now be accessible to European clinicians to simplifying the dressing of wounds on difficult-to-protect articulating regions such as for example knee or elbow joints while also offering advanced antimicrobial protection.’ The CE Mark Certification for Acticoat Flex was received by Smith Nephew the other day following the July 510 clearance in the United States and market acceptance in Canada late last year.